Keywords: merck, victorious, cox-2, patent, dispute, monsanto, subsidiary

Merck victorious in COX-2 patent dispute

Article | 11 October 1999

Print This

Monsanto subsidiary GD Searle, which developed and markets theCOX-2 inhibitor Celebrex (celecoxib), has been unsuccessful in its pursuit of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in